Evidence map›Paper›PMID 35686823›Full record

ArticleHealthcare policy = Politiques de sante2022

Commentary: Fulfilling the Promise of Global Access Licensing Principles to Enable Equitable Access.

Reshma Ramachandran

Abstract readComment
In one paragraph

Article in Healthcare policy = Politiques de sante, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. New Spending Programs and Old Frustrations: Where Is the Vision?Healthcare policy = Politiques de sante · 2022
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Reshma RamachandranPostdoctoral Fellow, National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, Physician Fellow, Veterans Affairs Connecticut Healthcare System Yale University, Connecticut, US.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In their piece, Herder and colleagues (2022) reveal the university origins of a key technology used in COVID-19 mRNA vaccines. They note that despite federal funding support and the university adopting "Global Access Principles," equitable, global access remains a challenge - in part due to the university's technology transfer practices. While for the past two decades university students have been successful in engaging institutional technology transfer offices in adopting similar access principles, implementation of these principles has been limited. This rejoinder points to the need for greater federal oversight and regulation to incentivize university action that enables equitable, global access.

Indexed as

COVID-19HumansLicensureUniversities

Identifiers

PMID35686823
PMCPMC9170054

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.